AstraZeneca's Japan partner to go solo on future cancer drug

Daiichi Sankyo is expanding its sales and development staff overseas, aiming to boost production capacity so that it can handle its cancer drugs business entirely on its own.

Related Keywords

Japan , Japanese , Daiichi Sankyo , Hiroyuki Okuzawa , Astrazeneca , Cancer , Pharmaceuticals , Medicine , Enhertu ,